France seeks speedy verdict on AstraZeneca vaccine

France announced that a swift verdict is required on the AstraZeneca vaccine’s safe use.

WHO finds animals responsible for Covid-19
England must delay in lifting COVID restrictions – Experts
Pakistan rejects US claims regarding loans in CPEC

France announced that a swift verdict is required on the AstraZeneca vaccine’s safe use.

Europe’s medicines regulator will confirm the safety concerns. Moreover, the other countries with suspicion over the jab, like Sweden, have suspended the use of shots. Germany, France, Italy, and Spain followed several other EU countries stopped AstraZeneca vaccinations pending investigation by the European Medicines Agency (EMA).

It has been said that the vaccine forms blood clots in the human body which are next-level dangerous to human health. The World Health Organization (WHO) and the EMA have said there is no proven link between the clots and the jab.

The head of France’s vaccination program, Alain Fischer, also said that a significant number of people have come across this incident. Therefore, it is essential to stop the jabs right now.  

The German health minister, Jens Spahn, said on Monday the decision to suspend the shot was based on expert advice. Denmark and Norway last week reported incidents of bleeding, blood clots. With that, there has been a significant decrease in red blood cells also. A 60-year-old Danish recipient has since died from a blood clot.

The WHO’s chief scientist, Soumya Swaminathan, said that countries should continue with the vaccine. Also, they did not find any link between the events and vaccination. Moreover, the benefits of vaccines outweigh the potential risk of side-effects.